Supervised and Unsupervised Approaches for Analyzing Covariation and Phenotypic Impact of HIV Drug Resistance Mutations. - Tobias Sing; Niko Beerenwinkel; Thomas Lengauer; Valentina Svicher; Francesca Ceccherini-Silberstein; Carlo-Federico Perno (LWA, 2005)

Characterization of Novel HIV Drug Resistance Mutations Using Clustering, Multidimensional Scaling and SVM-Based Feature Ranking. - Tobias Sing; Valentina Svicher; Niko Beerenwinkel; Francesca Ceccherini-Silberstein; Martin Däumer; Rolf Kaiser; Hauke Walter; Klaus Korn; Daniel Hoffmann; Mark Oette; Jürgen K. Rockstroh; Gerd Fätkenheuer; et al. (PKDD, 2005)

Molecular Dynamics and Free Energy Studies on the Wild-Type and Mutated HIV-1 Protease Complexed with Four Approved Drugs: Mechanism of Binding and Drug Resistance. - Stefano Alcaro; Anna Artese; Francesca Ceccherini-Silberstein; Francesco Ortuso; Carlo-Federico Perno; Tobias Sing; Valentina Svicher (J. Chem. Inf. Model., 2009)

Detecting and understanding genetic and structural features in HIV-1 B subtype V3 underlying HIV-1 co-receptor usage. - Mengjie Chen; Valentina Svicher; Anna Artese; Giosuè Costa; Claudia Alteri; Francesco Ortuso; Lucia Parrotta; Yang Liu 007; Chang Liu; Carlo-Federico Perno; Stefano Alcaro; Jing Zhang 010 (Bioinform., 2013)

Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach. - Francesca Alessandra Ambrosio; Giosuè Costa; Isabella Romeo; Francesca Esposito; Mohammad Alkhatib; Romina Salpini; Valentina Svicher; Angela Corona; Paolo Malune; Enzo Tramontano; Francesca Ceccherini-Silberstein; Stefano Alcaro; et al. (J. Chem. Inf. Model., 2023)